Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- PE ratio
- —
- Forward PE
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 19,000
- Avg volume
- 61,882
- Day's range
- $0.03 – $0.03
- Shares out
- —
- Stochastic %K
- 68%
- Beta
- —
- Analysts
- Strong Buy
- Price target
- —
Company profile
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and...
Show more
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to support clinical decision making at the point of care. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.
- Industry
- Medical Devices
- Sector
- Healthcare
- Website
- https://www.acarix.com
- Address
- Regus MalmOe, Hyllie Boulevard 34, 5TR, Malmö, Sweden
Latest news
No headlines yet.
